AR023273A1 - Sintesis de antibioticos carbamato cetolidos. - Google Patents

Sintesis de antibioticos carbamato cetolidos.

Info

Publication number
AR023273A1
AR023273A1 ARP000105057A ARP000105057A AR023273A1 AR 023273 A1 AR023273 A1 AR 023273A1 AR P000105057 A ARP000105057 A AR P000105057A AR P000105057 A ARP000105057 A AR P000105057A AR 023273 A1 AR023273 A1 AR 023273A1
Authority
AR
Argentina
Prior art keywords
antibiotics
cetolidos
carbamato
synthesis
preparing
Prior art date
Application number
ARP000105057A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR023273A1 publication Critical patent/AR023273A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Esta invencion se refiere a un procedimiento para preparar un antibiotico macrolido de formula 1 en la que R1, R2, R3, R4 y R5 son como se han definidoantes. Estos antibioticos son utiles como agentes antibanterianos y antiprotozoarios en mamíferos,incluyendo a los seres humanos, así como a los peces y aves.La invencion tambien incluye nuevos compuestos preparados mediante la preparacion del antibiotico macrolido.
ARP000105057A 1999-09-29 2000-09-27 Sintesis de antibioticos carbamato cetolidos. AR023273A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15655499P 1999-09-29 1999-09-29

Publications (1)

Publication Number Publication Date
AR023273A1 true AR023273A1 (es) 2002-09-04

Family

ID=22560054

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105057A AR023273A1 (es) 1999-09-29 2000-09-27 Sintesis de antibioticos carbamato cetolidos.

Country Status (18)

Country Link
EP (1) EP1088828A3 (es)
JP (1) JP2001151792A (es)
KR (1) KR20010050704A (es)
CN (1) CN1289778A (es)
AR (1) AR023273A1 (es)
AU (1) AU6129300A (es)
BR (1) BR0004537A (es)
CA (1) CA2321336C (es)
CZ (1) CZ20003567A3 (es)
HU (1) HUP0003834A3 (es)
ID (1) ID27331A (es)
IL (1) IL138633A0 (es)
IN (2) IN187119B (es)
PL (1) PL342917A1 (es)
RU (1) RU2188827C2 (es)
TR (1) TR200002787A2 (es)
YU (1) YU57900A (es)
ZA (1) ZA200005139B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070174A2 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
CA2476448A1 (en) 2002-02-15 2003-08-28 Sympore Gmbh Antibiotic conjugates
WO2003070173A2 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
CN102199180B (zh) * 2011-04-12 2014-07-09 连云港杰瑞药业有限公司 一种卡培他滨的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
JP2000513026A (ja) * 1997-06-11 2000-10-03 ファイザー・プロダクツ・インク ９−オキシム エリスロマイシン誘導体
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.

Also Published As

Publication number Publication date
RU2188827C2 (ru) 2002-09-10
ZA200005139B (en) 2002-03-26
CA2321336A1 (en) 2001-03-29
HUP0003834A3 (en) 2001-07-30
KR20010050704A (ko) 2001-06-15
PL342917A1 (en) 2001-04-09
EP1088828A2 (en) 2001-04-04
YU57900A (sh) 2003-02-28
CZ20003567A3 (cs) 2002-01-16
TR200002787A2 (tr) 2001-04-20
IL138633A0 (en) 2001-10-31
CN1289778A (zh) 2001-04-04
HU0003834D0 (en) 2000-09-28
IN188930B (es) 2002-11-23
CA2321336C (en) 2005-03-15
BR0004537A (pt) 2001-04-17
HUP0003834A2 (hu) 2001-05-28
IN187119B (es) 2002-02-09
ID27331A (id) 2001-03-29
EP1088828A3 (en) 2001-04-11
JP2001151792A (ja) 2001-06-05
AU6129300A (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AR018705A1 (es) Procedimientos e intermedios para preparar compuestos anticancerosos.
AR008861A1 (es) COMPUESTOS DE LACTAMA E IMIDA HETEROCICLICOS DE ARALQUILO Y ARALQUILEDENO, COMPUESTOS INTERMEDIARIOS PARA SU SíNTESIS, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
CO4970773A1 (es) Nuevos derivados de eritromicina
ES2184070T3 (es) Derivados de oximas sustituidas utiles como antagonistas de la neuroquinina.
AR028985A1 (es) Compuestos derivados de quinolin-2-ona- sustituidos con heteroarilo utiles como agentes anticancerigenos, procedimiento de tratamiento de enfermedades utilizando dicho compuesto, composicion farmaceutica que lo contiene
AR028948A1 (es) Compuestos novedosos
SV1998000008A (es) Inhibisores de sulfamida-metaloproteasa. ref. ran 4070\114
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
CO4950563A1 (es) Nuevos compuestos
HN2000000003A (es) Antibioticos cetolidos
BR0112863A (pt) Antibióticos macrólidos
ES2188984T3 (es) Procedimiento de enriquecimiento en r de epimeros de derivados de 16,17-acetales de derivados de 21-aciloxi-pregnano-1,4-dieno-11-beta, 16alfa-triol-3,20-dionas.
PA8582201A1 (es) Indoles 2,7-sustituidos
AR024747A1 (es) Derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen.
AR023273A1 (es) Sintesis de antibioticos carbamato cetolidos.
GT199800162A (es) Derivados de eritromicina triciclicos.
AR028947A1 (es) Compuestos novedosos
ES2192334T3 (es) Procedimiento mejorado para preparar un agente antiparasitario.
UY27770A1 (es) Imidazolinilmetil aralquilsulfonamidas
YU37597A (en) New pyranosid derivatives
ES2163316T3 (es) Procedimiento para la alquilacion de sulfonamidas impedidas.
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
HN1999000082A (es) 3-ceto derivados triciclicos de 6-0- metileritromicina.
ATE190334T1 (de) Azlacton-derivatisierte polyamide

Legal Events

Date Code Title Description
FB Suspension of granting procedure